I’ve seldom heard of impersonating an FDA official. Evidently its happening. Here is the FDA press release:
FDA Warns Public of Continued Extortion Scam by FDA Impersonators
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm195814.htm
GxP Perspectives
Commentary on FDA, clinical trials, research ethics, GCP, drug safety, and FDA Warning Letters
RSS- GxP Perspectives Calls it a Day
- Three Things That You Should Know About Part 11
- FDA & EMA Regulatory Developments for eSubmissions
- FDA IP Labeling Requirements
- Quantifying Quality for GxP Compliance
- FDA & Politics: In the Interest of Science?
- TMF Reference Model Update
- India: Quality for Clinical Trials
- European Qualified Persons & New EU Anti-Falsification Legislation
- Drug Accountability in Clinical Trials
Recent Comments
GxP Perspectives on Clinical Trial Protocol Deviat… Sandra Storli on Clinical Trial Protocol Deviat… GxP Perspectives on Drug Accountability in Clinica… Shari Fox on Drug Accountability in Clinica… How the FDA Regulate… on FDA Releases Draft Guidance fo…
that one is weird
It sure is. I have rarely heard of anyone trying to impersonate an FDA person. Seems there is a new scam every day. Maybe its the mess the economy is in.
People posing as FDA Investigators/Inspectors has happened several times in the past. Mostly to try to obtain “samples” of stuff for free.
Thanks Robert- People should know that Robert Coleman was a national expert for drugs and an educator at FDA prior to retiring and becoming a drug GMP consultant. He was the lead instructor at several of FDA courses I took including basic drug school.